Optimi Health Corp. (OPTI)
CSE
Closed
Aug 24, 2026
Day's Range
6.7352 wk Range
4.95Overview - OPTI - Optimi Health Corp.
Key Statistics
Valuation
Enterprise Value
31.12M
P/E (Trailing)
‪-5.66‬
P/E (Forward)
‪-10.65‬
Price / Sales (TTM)
‪222.29‬
Price / Book
‪1.66‬
EV / EBITDA
‪-7.39‬
Profitability
Gross Margin
‪89.91%‬
Profit Margin
‪-15.98%‬
Operating Margin
‪-957.82%‬
Return on Assets
‪-16.06%‬
Return on Equity
‪-54.36%‬
Ownership
Shares Outstanding
3.22M
Float
4.65M
Held by Insiders
‪12.65%‬
Held by Institutions
‪7.74%‬
Price stats
Beta
‪1.60‬
50-Day Avg
‪6.57‬
200-Day Avg
‪8.74‬
Dividends
Payout Ratio
‪0.00%‬
Shariah Compliance
Report Date: Feb 16, 2025
Screened by Zoya using the AAOIFI methodology.
Peers - OPTI - Optimi Health Corp.
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on CSE.
Profile Summary - OPTI - Optimi Health Corp.
About
Optimi Health Corp. is a commercial-stage pharmaceutical company focused on the manufacturing and distribution of regulated psychedelic drug products. The company produces finished-dose psilocybin and MDMA capsules, along with active pharmaceutical ingredients, at a Health Canada-licensed, GMP-compliant facility in…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
